We discuss the existing data on anal precancers and demonstrate the impact of evidence gaps and uncertainty on a clinical decision model developed to provide clinical guidance for management of anal precancers.
Keywords: Anal precancer; clinical epidemiology; clinical recommendations; cost effectiveness; uncertainty.